Continuous Glucose Monitoring (CGM) Systems/Devices Market Size, Share & Trends Report

Continuous Glucose Monitoring (CGM) Systems/Devices Market Size, Share & Trends Analysis Report By Component (Transmitters, Sensors, Insulin Pumps), By End Use (Hospitals, Homecare), And Segment Forecasts, 2018 - 2024

  • Published Date: Jul, 2018
  • Base Year for Estimate: 2015
  • Report ID: 978-1-68038-875-6
  • Format: Electronic (PDF)
  • Historical Data: 2013 - 2015
  • Number of Pages: 55

Industry Insights

The global continuous glucose monitoring systems/devices market size was valued at USD 361.5 million in 2016 and is anticipated to witness a CAGR of 13.7% during the forecast period. Growing cases of diabetes, coupled with increasing adoption of continuous glucose monitoring (CGM) devices, has been driving the market. CGM systems are minimally invasive and offer an easy and effective way to manage diabetes. They can also detect drastic changes in blood glucose level, thereby preventing hypoglycemic conditions.

U.S. CGM devices market

These devices facilitate analysis of blood glucose levels at different time intervals with the help of a sensor. Respective readings fed into to a diabetes management software through a wireless network allow patients to understand the disease better, thereby helping them to manage it in a more effective way.

Smoking, obesity, physical inactivity, and high blood pressure and high cholesterol are the common risk factors associated with diabetes complications. According to the data published inNational Diabetes Statistics Report 2017 by Centers for Disease Control and Prevention (CDC) indicate diabetes as the seventh leading cause of death in U.S.

It also provides patients with insights about food consumption, medication, physical activities, and illnesses. The advent of digital therapeutics has further aided CGM device manufacturers to reach out to diabetic patients. Various apps are available in the market that integrate data collected from CGM devices for future trend analysis and subsequent changes to be made in the patient’s lifestyle. All these factors are expected to have a positive impact on the market growth.

Component Insights

Based on component type, the CGM systems market is segmented into transmitters and receivers, sensors, and insulin pumps. Since transmitters and receivers are the most integral part of these devices, they accounted for the largest market share in the past. A transmitter works along with receiver to collect the readings from sensor and displays the results on device monitor.

A battery-powered, hand-held receiver that displays the results receives signals from the transmitter. The receiver also displays various graphs and statistics that can be used for customization of medication, which is helpful for individuals suffering from hyperglycemic or hypoglycemic conditions.

Insulin pumps segment is anticipated to expand at the highest CAGR of 15.3% during the forecast period. These devices are designed specifically to administer insulin levels. Insulin pumps eliminate the need of individual glucose injections while delivering insulin more accurately and reducing unpredictable effects of intermediate or long-acting insulin.

CGM sensors are the most sophisticated part of the device. These sensors use glucose oxidase to detect blood sugar levels. Glucose oxidase converts glucose to hydrogen peroxidase, which reacts with the platinum inside the sensor, producing an electrical signal to be communicated into the transmitter.

End-use Insights

On the basis of end use, the market is segmented into hospitals, homecare settings, and others such as clinical laboratories and diagnostic centers. Homecare settings segment led the global market and is anticipated to witness the highest CAGR during the forecast period. These devices offer patients with reduced intake of insulin doses and facilitate continuous monitoring of blood glucose levels. Homecare settings are expected to fuel the demand for CGM devices because of efficient and easy monitoring of blood glucose.

China CGM devices market

Rising number of hospital visits for diabetes treatment are responsible for the increasing adoption of these devices in hospitals. Complications caused due to diabetes, such as retinopathy, nephropathy, and neuropathic, require hospital admissions. Thus, hospital settings are also anticipated to capture a significant market share in the near future.

Regional Insights

The North American region is expected to lead the global market. Increasing cases of diabetes and efforts taken by the national government to manage the disease at a larger level are expected to drive the region’s growth. Rising adoption of alternate and novel devices have been witnessed in the region, accelerating market growth.

Preventive measures taken by the government to help diabetic individuals understand and manage the disease before serious consequences occur are the key driver for the regional market.The region is expected to flourish owing to technological advancements and substantial research and innovation in diabetes care.

Asia Pacific region is anticipated to witness the highest CAGR during the forecast period. According to the Asian Diabetes Prevention Initiative, almost 60% of the world’s diabetic population resides in the Asia Pacific region. High prevalence of the disease in developing countries such as India and China has been propelling market growth in the region. Moreover, rising healthcare expenditure, increasing investment by companies, and favorable regulatory policies are also positively affecting the market growth in this region.

Continuous Glucose Monitoring Systems Market Share Insights

The market constitutes a large number of global and regional companies. Some of the key players in the industry are Pfizer Inc.; Baxter International Inc.; Abbott Laboratories; Medtronic, Inc.; Animas Corporation; Novo Nordisk; Ypsomed; and GlySens. Most of these leading companies are involved in strategic collaborations, mergers and acquisitions, and regional expansions to gain high revenue share in the industry.

For instance, in January 2016, Ypsomed AG strengthened their existing partnership with Tonghua Dongbau Pharmaceutical, appointing it as their exclusive distributor for their range of products in China.

Companies are also increasingly developing new products, which has further aided in the expansion of their existing portfolio with advanced technologies. For instance, in February, 2016 Animas Corporation announced the launch of Animas Academy in the Ireland and U.K., which is an educational program for individuals managing diabetes with an insulin pump and supplementary technology associated with it.

Report Scope

Attribute

Details

Base year for estimation

2015

Actual estimates/Historical data

2013 - 2015

Forecast period

2016 - 2024

Market representation                         

Revenue in USD Million and CAGR from 2016 to 2024

Regional scope

North America, Europe, Asia Pacific, Latin America, and Middle East Africa

Country scope

U.S., Canada, Germany, U.K., China, India, Brazil, Mexico, South Africa, Saudi Arabia

Report coverage  

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2013 to 2024. For the purpose of this study, Grand View Research has segmented the global continuous glucose monitoring systems/devices market report on the basis of component, end use, and region:

  • Component Outlook (Revenue, USD Million, 2013 - 2024)

    • Transmitters & Receivers

    • Sensors

    • Insulin Pumps

  • End-use Outlook (Revenue, USD Million, 2013 - 2024)

    • Hospitals

    • Homecare Settings

    • Others

  • Regional Outlook (Revenue, USD Million, 2013 - 2024)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

      • Saudi Arabia

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,450
Multi User (2-5) - $6,450
Compass Access - $8,450

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified